CD8A | CD8a molecule | CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD8B | CD8b molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD96 | CD96 molecule | CD markers Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CDA | Cytidine deaminase | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CDCA4 | Cell division cycle associated 4 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CDCA5 | Cell division cycle associated 5 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CDH4 | Cadherin 4, type 1, R-cadherin (retinal) | Predicted membrane proteins
| | | | | Tissue enhanced |
CEACAM21 | Carcinoembryonic antigen-related cell adhesion molecule 21 | Predicted membrane proteins
| | | | | Tissue enhanced |
CENPU | Centromere protein U | Predicted intracellular proteins
| | | | | Tissue enhanced |
CETP | Cholesteryl ester transfer protein, plasma | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CFP | Complement factor properdin | Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CHI3L1 | Chitinase 3-like 1 (cartilage glycoprotein-39) | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CHI3L2 | Chitinase 3-like 2 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CHMP7 | Charged multivesicular body protein 7 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CHRM4 | Cholinergic receptor, muscarinic 4 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CHRNA4 | Cholinergic receptor, nicotinic, alpha 4 (neuronal) | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CKAP2L | Cytoskeleton associated protein 2-like | Predicted intracellular proteins
| | | | | Tissue enhanced |
CLDN9 | Claudin 9 | Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC12A | C-type lectin domain family 12, member A | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC2D | C-type lectin domain family 2, member D | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC4A | C-type lectin domain family 4, member A | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC4C | C-type lectin domain family 4, member C | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC4E | C-type lectin domain family 4, member E | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC6A | C-type lectin domain family 6, member A | Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC7A | C-type lectin domain family 7, member A | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC9A | C-type lectin domain family 9, member A | Predicted membrane proteins
| | | | | Tissue enhanced |
CLECL1 | C-type lectin-like 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CLLU1OS | Chronic lymphocytic leukemia up-regulated 1 opposite strand | Predicted intracellular proteins
| | | | | Tissue enhanced |
CNTF | Ciliary neurotrophic factor | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CPLX3 | Complexin 3 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CR1 | Complement component (3b/4b) receptor 1 (Knops blood group) | Blood group antigen proteins CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CR1L | Complement component (3b/4b) receptor 1-like | Predicted secreted proteins
| | | | | Tissue enhanced |
CRABP1 | Cellular retinoic acid binding protein 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CRHBP | Corticotropin releasing hormone binding protein | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CRLF2 | Cytokine receptor-like factor 2 | Cancer-related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CRTAM | Cytotoxic and regulatory T cell molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CSF2RB | Colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CSF3 | Colony stimulating factor 3 (granulocyte) | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CSF3R | Colony stimulating factor 3 receptor (granulocyte) | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CSNK2B-LY6G5B-1181 | Chimera CSNK2B-LY6G5B splicing isoform 1181 {ECO:0000313|EMBL:CCI79697.1}; Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000365040} | Predicted intracellular proteins
| | | | | Tissue enhanced |
CTB-133G6.1 | | Predicted membrane proteins
| | | | | Tissue enhanced |
CTD-2207O23.3 | Rho guanine nucleotide exchange factor 18 {ECO:0000313|Ensembl:ENSP00000471597} | Predicted intracellular proteins
| | | | | Tissue enhanced |
CTD-2370N5.3 | | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CTD-3088G3.8 | Protein LOC388210 {ECO:0000313|Ensembl:ENSP00000471908} | Predicted intracellular proteins
| | | | | Tissue enhanced |
CTD-3214H19.16 | | Predicted intracellular proteins
| | | | | Tissue enhanced |
CTLA4 | Cytotoxic T-lymphocyte-associated protein 4 | CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CTSW | Cathepsin W | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CXCL1 | Chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CXCL10 | Chemokine (C-X-C motif) ligand 10 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CXCL11 | Chemokine (C-X-C motif) ligand 11 | Predicted secreted proteins
| | | | | Tissue enhanced |